Global Bioinformatics Market
Size - Industry Trends & Outlook Report 2026
Development of the
bioinformatics market is determined by the rising request for nucleic acid and
protein sequencing, growing government edges and backing, and growing use of
bioinformatics in drug discovery and biomarker development processes. With the
outline of upcoming types of machinery such as nanopore sequencing
(third-generation sequencing technique) and cloud calculating, the market is
expected to offer noteworthy opportunities for manufacturers of bioinformatics
solutions. Though, issues such as a shortage of skilled personnel to ensure the
right use of bioinformatics tools and lack of integration of a large variety of
data generated through many bioinformatics platforms are obstructing the market
Global Bioinformatics Market:
Market Outlook and Trends
Bioinformatics is a combination
of information technology and biology, which links biological data with methods
for information storage, spreading, and inspection to upkeep various areas of
scientific research, counting biomedicine. It uses software tools for file
creation, data management, data warehousing, data withdrawal, and others.
Mining these data leads to scientific detections, which are used in the study
of heredities & genomes. Several bioinformatics tools are obtainable in the
market. They are categorized as protein functional & analysis tools,
homology & resemblance tools, sequence examination tools, and miscellaneous
tools. The field covers many advanced and specialized areas of life, such as
structural genomics, functional genomics, DNA microarrays, relative genomics,
medical facts, and others. Hence, these factors mentioned above help in growing
the worldwide bioinformatics market share.
Global Bioinformatics Market
Growing demand for nucleic acid
and protein sequencing due to reductions in sequencing costs and technological
Bioinformatics is progressively
being used to recognize genes in DNA sequences. The information collected is
used to know the molecular mechanisms of diseases. This assists in developing
better treatments and diagnostic tests. Due to important discounts on costs of
sequencing, many scientific research institutes and biotechnology companies
have undertaken initiatives to perform sequencing studies at their amenities.
Similarly, sequencing and data analysis and clarification can now be finished
within days after the growth of quicker and sophisticated bioinformatics tools.
With progressions in technology, there has been a surge in the speed of
translating genetic sequences, which has decreased the complete cost of
sequencing and analysis per sample. The reasons behind this reduction in cost
include the growth of advanced DNA sequencing platforms and various
Increasing funding will drive
the growth of the market
IT giants have started focusing
on bioinformatics for healthcare applications. Investments are being made for
more advanced tests and techniques in battling diseases such as cancer and
Parkinson’s. Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos have
invested millions of dollars in Grail, a start-up by gene sequencing firm
Illumina that a former Google executive lead. Grail is emerging a
cancer-screening blood test for persons, even if they show no indications. The
test’s development is foreseeable to require many samples to be sequenced and inspected
by using more whole bioinformatics tools and databases.
Impact of COVID-19 in industry
COVID-19 has had an influence on
economies – and segments within those economies. Some industries have
struggled, and others have started to flourish. One of those where there has
been a vital move in development is bioinformatics. As a result, this market is
now estimated to grow meaningfully, not just during the residual months in
which COVID-19 is a leading factor but in the post-COVID retrieval period too.
Global Bioinformatics Market:
By Product Type, the
bioinformatics stages section is expectable to be the firmest-rising section in
the prediction period. Knowledge management tools demanded the major market
share in the global bioinformatics market in 2018, while the bioinformatics platforms
section is foreseeable to be the fastest-rising section in the prediction
period. The main issue driving the growth of bioinformatics platforms is their
growing use in many genomic applications. In addition, the use of
bioinformatics platforms is growing in the drug discovery & growth process,
which is causal to market growth. Though, the lack of standardization in
bioinformatics platforms through the industry is restrictive development of the
bioinformatics platforms market, due to which bioinformatics professionals must
work with fluctuating standards and platforms that give no reproducible
By Application, the metabolomics
section is predictable to produce at the highest CAGR during the prediction
period. Factors such as the obtainability of research funding and government
support are driving market growth. However, metabolomes cannot be easily
identified or figured from reconstructed biochemical trails due to enzymatic
variety, substrate ambiguity, and the difference in governing mechanisms.
Hence, the annotation of unidentified metabolic signals is the main
interruption to the growth of the metabolomics section.
By Sector, the medical
biotechnology segment is expected to grow at the highest CAGR during the
forecast period. Numerous pharmaceutical companies are progressively accepting
bioinformatics tools to decline the cost and time involved in drug discovery.
Bioinformatics methods for target detection and authentication are proving more
competent than old-style methods. With the help of bioinformatics tools, much
of the information concerning drug candidates is authenticated at a molecular
level, which inclines to decrease drug attrition rate in the later stages of
drug development. Thus, donating to the success of more drug candidates in the
clinical trials is making the drug growth progression more cost actual. Geographically,
the Bioinformatics market has been separated into North America, Europe, Asia
Pacific, South America, and the Middle East & Africa.
Global Bioinformatics Market: Regional
The market in the Asia Pacific
region is predictable to propose noteworthy chances for players to offset
income losses sustained in established markets. Developing countries in this
region are watching development in their GDPs and an essential increase in
disposable income levels. This has led to augmented healthcare disbursements by
a more extensive population base, healthcare infrastructure innovation, and
rising diffusion of cutting-edge research and clinical laboratory technologies,
counting bioinformatics, in Asia Pacific countries. These issues are
predictable to provide noteworthy growth chances to bioinformatics companies
working in this region.
The leading players in the
Bioinformatics Market include Agilent Technologies, Inc., Geneva Bioinformatics
(Genebio), Dassault Systems, Eurofins Scientific, Illumina Inc., Bruker
Daltonics Inc., Biomax Informatics AG, Perkinelmer Inc., Qiagen N.V, and Thermo
Fisher Scientific, Inc. The other players in the value chain include Accelrys,
Inc., Affymetrix, Inc., SA Nonlinear Dynamics, Quest Diagnostics, Inc., and
Ø In April 2019, The HANS-GINS Indxx
Healthcare Innovation Ucits ETF will focus on developments in sectors including
bioinformatics, bioengineering, genome sequencing, healthcare trackers,
nanotechnology, neuroscience, robotics and medical devices.
Ø In March 2017, Agilent Technologies
Inc. introduced its first comparative genomic hybridization (CGH) assay which
will be used for diagnostic purposes: the GenetiSureDx Postnatal Assay. This
will help the clinical geneticists to detect genetic anomalies early with more
accuracy as compared to than traditional methods.
Scope of Report
Historical data – 2016-2018
Base Year – 2019
Forecast – 2020 – 2026
Revenue in USD Billion
U.S, Canada, Germany, UK, France, Italy,
Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa,
Saudi Arabia .
By Product Type, By Application, By Sectors,
leading players considered for market analysis are Agilent Technologies,
Inc., Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific,
Illumina Inc., Bruker Daltonics Inc., Biomax Informatics AG, Perkinelmer
Inc., Qiagen N.V, and Thermo Fisher Scientific, Inc. The other players in the
value chain include Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics,
Quest Diagnostics, Inc., and others.
ü Sequence Analysis Platforms
ü Sequence Alignment Platforms
ü Sequence Manipulation Platforms
ü Structural Analysis Platforms
Knowledge management tools
ü Generalized Knowledge Management Tools
ü Specialized Knowledge Management Tool
ü Proteomics & Metabolomics
ü North America
ü Asia Pacific
ü South America
ü Middle East & Africa
The objective of
• To analyze and
forecast the Global Bioinformatics Market size of the market in terms of value.
• To examine the
careful market segmentation and forecast the market size, in terms of value,
based on the region by segmenting.
• The Global Bioinformatics Market into
five regions, namely, North America, Europe, Asia Pacific, Middle East, South
America, and their leading countries.
• To outline,
categorized, and forecast the Global Bioinformatics Market based on the By
Product Type, By Application, By Sectors, and By Regional.
• To examine
competitive developments, like By Products Type, By Application, By Sectors, By
Regional within the Global Bioinformatics Market.
• To highlight
the impact analysis of the factors affecting the market dynamics such as growth
strategically profile the key players and comprehensively analyze their market
shares along with detailing the competitive landscape for market leaders.
Business Questions Answer by the Report
Ø How will the
market drivers, restraints, and opportunities affect the market dynamics?
Ø What will be the
market size in terms of value and volume and market statistics with a detailed
Ø Which segment
dominates the market or region, and one will be the fastest - growing, and why?
Ø A comprehensive
survey of the competitive landscape and the market participant players
Ø Analysis of
strategy adopted by the key player and their impact on other players.
Customization Scope for the Client
satisfaction is our first and last priority, and that is why BlueWeave
Consulting offers customization according to Company’s specific needs. The
following customization options are available for the report:
Additional Company Information
• With five additional company detail
• Additional country analysis
• Detailed segment analysis